SecProbe.io

<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

                               CHISTE CORPORATION
                       936A BEACHLAND BOULEVARD, SUITE 13
                              VERO BEACH, FL 32963
                                 (772) 231-7544
                               (772) 231-5947 FAX

                                  June 16, 2005

VIA EDGAR AND FACSIMILE
-----------------------

Mara L. Ransom, Esq.
Special Counsel
Office of Mergers and Acquisitions
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC  20549

                  Re:      Chiste Corporation
                           Information Statement Pursuant to Section 14(f) of
                           the Securities Exchange Act of 1934 and Rule 14f-1
                           thereunder Filed May 31, 2005 File Number 5-61797

Dear Ms. Ransom:

      On behalf of Chiste Corporation (the "Company"), we respond as follows to
the Staff's comments received on June 13, 2005 under letter dated June 10, 2005
relating to the above-captioned Information Statement. Captions and page
references herein correspond to those set forth in your letter. Please note that
for the Staff's convenience, we have recited each of the Staff's comments and
provided the Company's response to each comment immediately thereafter.

                              INFORMATION STATEMENT
                              ---------------------

1. PLEASE ELABORATE UPON THE AMOUNT AND SOURCE OF CONSIDERATION USED TO EFFECT
THE CHANGE OF CONTROL TRANSACTION. SPECIFICALLY, WHILE WE NOTE THAT SHARES OF
SERIES B CONVERTIBLE PREFERRED STOCK WERE ISSUED PURSUANT TO THE TERMS OF THE
EXCHANGE AGREEMENT, IT IS NOT CLEAR HOW MANY SHARES WERE ISSUED OR IN WHAT
PROPORTION TO EACH MEMBER OF HYDROGEN. SEE ITEM 6(E) OF SCHEDULE 14A.

      The transactions contemplated under the Exchange Agreement were not
completed as of the filing of the Information Statement and have not been
consummated to date. There are number of conditions to closing of the exchange
transaction, including a minimum amount of funds being raised in certain private
placements. There is no assurance that the conditions will be satisfied or that
the transactions will be closed. We have disclosed in the Information Statement
the pending nature of the exchange transaction and the significant conditions to
closing. The Exchange Agreement was also attached as an exhibit to our Current
Report filed on Form 8-K with the SEC on May 18, 2005.

<PAGE>

Mara L. Ransom, Esq.
June 16, 2005
Page 2

      The exact number of shares of Series B Preferred Stock to be issued in the
exchange transaction will depend on the amount of funds raised under the private
placements. However, as stated in the Information Statement, assuming all
conditions are satisfied, Chiste will, in all cases, issue shares of Series B
Preferred Stock representing 95.175% of its outstanding common stock on an fully
diluted and as converted basis.

      We believe our disclosures in the Information Statement are adequate and
appropriate based on the current status of the exchange transaction. Upon
closing of the exchange transaction, Chiste intends to file a Current Report on
Form 8-K, in the time required by SEC rules, which will provide the specific
numbers of shares of Series B Preferred Stock issued with respect to the
exchange transactions, how such shares are allocated to the various parties, and
other details of the transaction.

2. WE NOTE YOUR INDICATION THAT THE MANAGEMENT DESIGNATES AND THE KRM FUND
DESIGNATES ARE EXPECTED TO BE APPOINTED WITHIN 30 DAYS FOLLOWING THE CLOSING. WE
PRESUME THAT YOU WILL PROVIDE SHAREHOLDERS WITH THE IDENTITY OF THESE
APPOINTEES, ALONG WITH INFORMATION REQUIRED PURSUANT TO ITEM 401 OF REGULATION
S-K. PLEASE REVISE TO ADVISE SHAREHOLDERS AS TO HOW AND WHEN THEY WILL BE
NOTIFIED OF THIS INFORMATION.

      At the time of filing of the Information Statement, only two new directors
have been designated to become members of Chiste's board following the closing
of the exchange transaction. At closing, our sole current director will resign.
The other three members of the board will be designated following the closing
once they are identified. As such, at closing, there will be a change in a
majority of our directors whether or not the other three positions are filled at
closing.

      Chiste intends to file a Current Report on Form 8-K, in the time required
by SEC rules, disclosing the appointment of any new directors following closing.

COMMITTEES OF BOARD OF DOCTORS, PAGE 10
---------------------------------------

3. PLEASE REVISE TO ENSURE THAT YOU HAVE PROVIDED ALL OF THE INFORMATION
REQUIRED PURSUANT TO ITEM 7(D) OF SCHEDULE 14A, INCLUDING INFORMATION REGARDING
WHETHER OR NOT THE COMPANY HAS STANDING NOMINATING AND COMPENSATION COMMITTEES
AND, IF NOT, IN THE CASE OF A NOMINATING COMMITTEE, WHY NOT. SEE ITEM 7(D)(1)
AND (2) OF SCHEDULE 14A. PLEASE ALSO ENSURE THAT YOU HAVE PROVIDED THE REQUIRED
DISCLOSURE PURSUANT TO ITEMS 7(F) AND (H) OF SCHEDULE 14A.

      Chiste is not a "listed company" under SEC rules and is therefore not
required to have a compensation committee or a nominating committee. We do not
currently have a compensation committee. Our Board of Directors is currently
comprised of only one member, Kevin R. Keating, who is also our sole officer
acting as President, Secretary and Treasurer. We have no employees, and no

<PAGE>

Mara L. Ransom, Esq.
June 16, 2005
Page 3

operating business activities. Any compensation for our directors and officers
must be approved by our Board of Directors.

      Chiste neither has a nominating committee for persons to be proposed as
directors for election to the Board of Directors nor a formal method of
communicating nominees from shareholders. However, because the management and
directors of the Company are the same persons, our Board of Directors has
determined not to adopt a formal methodology for communications from
shareholders on the belief that any communication would be brought to the
Boards' attention by virtue of the co-extensive capacities served by Kevin R.
Keating.

      We intend to make any disclosure required by Items 7(d), (f) and (h) of
Schedule 14A in our Annual Report on Form 10-KSB for our fiscal year ended March
31, 2005 to be filed by June 30, 2005. We believe such disclosure is adequate
and appropriate for our stockholders based on the nature of the disclosure that
maybe required by these items and should be sufficient to rectify any disclosure
deficiency with respect to these items in our Information Statement.

SECURITY OWNERSHIP OF CERTAIN BENEFCIAL OWNERS AND MANAGEMENT, PAGE 18
----------------------------------------------------------------------

4. IN THE FUTURE, PLEASE NOTE THAT THE FOOTNOTES TO THE BENEFICIAL OWNERSHIP
TABLE SHOULD IDENTIFY THE NATURAL PERSON WHO CONTROLS, I.E. VOTING OR INVESTMENT
POWER, THE STOCK OWNED BY ENTITIES LISTED IN THE TABLE. SEE EXCHANGE ACT RULE
13D-3. FOR EXAMPLE, PLEASE DISCLOSE WHO HAS CONTROL OVER THE COMMON STOCK OWNED
BY KEATING REVERSE MERGER FUND, LLC AND AZTORE HOLDINGS, INC.

      We intend, in the future, to disclose the natural persons who control,
i.e. voting or investment power, the stock owned by entities listed in our
beneficial ownership table. We do not view any disclosure deficiency in our
Information Statement with respect to this item to be material, especially since
Keating Reverse Merger Fund, LLC and Aztore Holdings, Inc. will not be 5% or
more stockholders following the closing of the exchange transaction.

                         FORM 8-K FILED ON MAY 18, 2005
                         ------------------------------

5. WE NOTE THAT THIS DOCUMENT WAS FILED PURSUANT TO ITEMS 1.01 AND 9.01 OF FORM
8-K. IN LIGHT OF THE CHANGE IN CONTROL OF THE ISSUER, IT WOULD APPEAR THAT ITEMS
5.01 AND 5.02 ARE ALSO APPLICABLE AND, BECAUSE OF THE ISSUANCE OF THE SERIES B
PREFERRED STOCK, ITEM 3.02 IS ALSO APPLICABLE TO THIS CHANGE OF CONTROL
TRANSACTION. PLEASE REVISE TO FILE AN AMENDED FORM 8-K REFLECTING THESE
ADDITIONAL ITEMS AND THE RELATED DISCLOSURE, OR TELL US WHY YOU BELIEVE THOSE
ITEMS ARE NOT APPLICABLE TO THIS TRANSACTION. PLEASE ALSO RE-FILE THE DOCUMENT
ON EDGAR TO REVISE YOUR DISCUSSION UNDER ITEM 9.01 IN THE AMENDED FORM 8-K TO
INDICATE WHEN YOU WILL FILE THE REQUIRED FINANCIAL STATEMENTS IN CONNECTION WITH
THE BUSINESS ACQUIRED IN THE CHANGE OF CONTROL TRANSACTION, OR TELL US WHY YOU
BELIEVE SUCH INFORMATION IS NOT NECESSARY. SEE ITEM 9.01(A)(4) OF FORM 8-K.

      The above-referenced Form 8-K was filed to disclose Chiste's entry into a
material contract. The closing of the exchange transaction disclosed therein is
subject to a number of conditions. Since the closing has not occurred, there has

<PAGE>

not been a change of control. Upon the closing of the exchange transaction, we
intend to file a comprehensive Current Report on Form 8-K, in the time required
by SEC rules, with all required items on Form 8-K, including Items 3.02, 5.01,
5.02, and 9.01. As such, we do not believe it is appropriate to file an
amendment to the Form 8-K filed on May 18, 2005.

      The Company acknowledges that:

      o     The Company is responsible for the adequacy and accuracy of the
            disclosure in the filings;

      o     Staff comments or changes to disclosures in response to staff
            comments in the filings reviewed by the staff do not foreclose the
            Commission from taking any action with respect to the filing; and

      o     The Company may not assert staff comments as a defense in any
            proceeding initiated by the Commission or any person under the
            federal securities laws of the United States.

      If you have nay further questions or comments based on our response set
forth above, please kindly contact me as soon as possible.

                                          Very truly yours,

                                          /s/ Kevin R. Keating
                                          --------------------
                                          Kevin R. Keating
                                          President and Director

</TEXT>
</DOCUMENT>